Taiwan FDA registration f7c49e8f2c6ed542287f1037e84d525d

Lotus silk implants

TW: 洢蓮絲植入劑

Taiwan·Risk Class 3·AQTIS Medical BV·Registered Feb 10, 2015 – Feb 10, 2030Active

Registration details

Analysis ID: f7c49e8f2c6ed542287f1037e84d525d
Customs Code: DHA05602665900

Company information

Manufacturer: AQTIS Medical BV
Manufacturer Country: Netherlands
Authorized Representative: CLOVERS BIOTECHNOLOGY CO., LTD.

Product details

Intended Use: ELLANSÉ-S TEMPORARILY CORRECTS MODERATE TO SEVERE FACIAL WRINKLES AND OTHER IMPERFECT CONNECTIVE TISSUE OR CONDITIONS, AND ELLANSÉ-S USES THE BODY'S INFLAMMATORY RESPONSE TO COAT MICROPARTICLES AND STIMULATE THE GROWTH OF CONNECTIVE TISSUE, WHICH IS COMPLETELY ABSORBED BY THE BODY AND COMPLETELY REPLACES THE INJECTED GEL-LIKE CARRIER WITHIN A FEW MONTHS. The applicable dosage value of this product for a single course of treatment is 1ml. The safety and efficacy of this product for long-term use for more than 2 years have not been proven. Applicable parts: nasolabial folds. Increased efficiency: As detailed in the Chinese copy of the copy, the following blanks.
Product Type (Level 1): I General, Plastic Surgery and Dermatology
Import Information: Safety monitoring;; import

Dates and status

Registration Date: Feb 10, 2015
Expiry Date: Feb 10, 2030

About this record

Access comprehensive regulatory information for Lotus silk implants in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number f7c49e8f2c6ed542287f1037e84d525d and manufactured by AQTIS Medical BV. The authorized representative in Taiwan is CLOVERS BIOTECHNOLOGY CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.